Pulmonary Disease, Chronic Obstructive research hub
4 indexed studies · 3 currently recruiting
- recruiting
The London COPD Exacerbation Cohort
This study in London looks at people with an ongoing lung condition called COPD to understand why some have more flare-ups than others. We want to find out what makes these flare-ups happen and how they affect a person's health over time.
United Kingdom - recruiting
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
This study looks at how a specific inhaler (Budesonide/Glycopyrronium/Formoterol, or BGF) works for people with a lung condition called COPD in real clinics. It uses information from different ongoing studies to learn more about this treatment.
Canada · Germany · Greece - recruitingPHASE3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
This study is testing a new medicine, depemokimab, for adults aged 40-80 with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) and a specific type of inflammation. It aims to see if depemokimab improves symptoms and is safe when added to their usual inhaler treatment.
United States · Argentina · Australia - active not recruitingPHASE1
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
This study is testing a new medicine, GSK3862995B, for safety in healthy people and those with Chronic Obstructive Pulmonary Disease (COPD). It aims to see how well people tolerate the medicine and if it causes any side effects, starting with small doses.
United States · Germany · United Kingdom